Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)

TPEX:4186 Revenue

Taiwan Advance Bio-Pharmaceutical had revenue of 169.35M TWD in the half year ending June 30, 2025, with 31.46% growth. This brings the company's revenue in the last twelve months to 371.86M, up 9.75% year-over-year. In the year 2024, Taiwan Advance Bio-Pharmaceutical had annual revenue of 354.17M with 12.09% growth.

• Revenue (ttm): 371.86M
• Revenue Growth: +9.75%
• P/S Ratio: 2.66
• Revenue / Employee: 2.25M
• Employees: 165
• Market Cap: 990.00M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	354.17M	38.19M	12.09%
Dec 31, 2023	315.98M	-2.25M	-0.71%
Dec 31, 2022	318.24M	74.87M	30.77%
Dec 31, 2021	243.36M	7.79M	3.31%
Dec 31, 2020	235.57M	29.77M	14.47%